Market Tracker

07/25 5:16pm ET

Seattle Genetics Inc (NASDAQ:SGEN)

44.49
Delayed Data
As of 3:59pm ET
 +0.50 / +1.14%
Today’s Change
26.02
Today|||52-Week Range
49.66
-0.87%
Year-to-Date
What's in Store for these 5 Drug Stocks in Q2 Earnings?
9:06am / Zacks.com - Paid Partner Content
5 Things Celldex Therapeutics, Inc. Wants You to Know
Jul 13 / MotleyFool.com - Paid Partner Content
3 Stocks We're Buying Again
Jul 21 / MotleyFool.com - Paid Partner Content
AbbVie's ABT-414 Gets Rare Pediatric Disease Status in U.S.
Jul 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close43.99
Today’s open44.14
Day’s range43.64 - 44.55
Volume465,484
Average volume (3 months)920,992
Market cap$6.2B
Dividend yield--
Data as of 3:59pm ET, 07/25/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-18.55%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+17.45%
P/E ratioNM
Price/Sales17.21
Price/Book8.96

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-0.01-0.01%
ALNYAlnylam Pharmaceutic...+0.71+1.08%
OPKOPKO Health Inc-0.02-0.20%
MNKMallinckrodt Plc+0.32+0.48%
Data as of 4:02pm ET, 07/25/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$336.8M
Annual profit (last year)-$120.5M
Net profit margin-35.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts